Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2011 Financial Results
Date:8/4/2011

ies

13,155,98014,338,579Commitments and contingenciesEquity:Shareholders' equity:Common stock - no par value; 100,000,000 shares authorized;20,400,085 and 20,338,461 shares issued and outstandingas of June 30, 2011 and December 31, 2010, respectively

71,609,04370,778,874Retained earnings

9,897,5856,998,806Total shareholders' equity

81,506,62877,777,680Noncontrolling interests

(81,553)(62,205)Total equity

81,425,07577,715,475Total liabilities and equity

$  94,581,055$
92,054,054CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIESCondensed Consolidated Statements of Income(Unaudited)Three months ended June 30,Six months ended June 30,2011201020112010Net revenues

$  14,389,741$ 10,739,935$  25,056,668$  20,870,587Costs and expenses:Cost of products sold

1,283,160863,7252,070,0981,723,013Selling and marketing

5,904,4445,848,12311,193,02811,455,635Research and development

1,027,0481,034,8002,036,7211,808,668General and administrative

2,344,0641,782,8344,324,4553,664,037Amortization of product license right

171,726171,726343,453343,452Other

27,44228,86749,05555,414Total costs and expenses

10,757,8849,730,07520,016,81019,050,219Operating income

3,631,8571,009,8605,039,8581,820,368Interest income

52,26050,33495,169111,013Interest expense

(79,604)(405,956)(295,647)(751,908)Net income before income taxes

3,604,513654,2384,839,3801,179,473Income tax expense

(1,436,365)(374,461)(1,959,949)(586,198)Net income

2,168,148279,7772,879,431593,275Net loss at subsidiary attributable tononcontrolling interests

9,4717,52719,34817,607Net income attributable tocommon shareholders

$
2,177,619$
287,304$
2,898,779$
,882Earnings per share attributable to common shareholders- basic

$
.11$
.01$
.14$
.03- diluted

$
.11$
.01$
.14$
.03Weighted-average shares outstanding- b
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
5. Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
6. Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010
7. Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010
8. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
9. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application
11. Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014  Zafgen, ... the unmet needs of severely obese patients, today ... of beloranib, a selective inhibitor of methionine aminopeptidase ... a severe form of genetic obesity.  These results ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... , , LOUISVILLE, Colo. , Feb. ... to give a boom to body contouring practices in the ... VASER® Lipo System – comes this non-invasive ultrasound and massage ... only system that has a specific lymphatic massage component with ...
... , ATLANTA , ... ( Duarte, Calif. ), a leading research and treatment center ... to implement an electronic interface that links its TomoTherapy® Hi-Art® ... management system. The connection enables communication between the MOSAIQ and ...
Cached Medicine Technology:Body Contouring Gets Refined with MedSculpt 2City of Hope Testing New Communication Link Between Cancer Therapy System and Elekta Electronic Medical Record System 2City of Hope Testing New Communication Link Between Cancer Therapy System and Elekta Electronic Medical Record System 3
(Date:4/23/2014)... Five for-profit and non-profit organizations in Washington ... Proof of Concept grants to accelerate maturation of ... the Life Sciences Discovery Fund (LSDF) announced today. ... grant to the Washington Biotechnology & Biomedical Association ... train the next generation of entrepreneurs and help ...
(Date:4/23/2014)... about an increase in adolescents, marijuana use following the ... relief. According to a new study at Rhode Island ... states with and without medical marijuana laws, legalizing the ... The study is published online in advance of print ... , "Any time a state considers legalizing medical marijuana, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... popular high school sport in the United States with ... researchers in the Center for Injury Research and Policy ... and describe the occurrence and distribution patterns of basketball-related ... athletic training setting among adolescents and teens. , The ... Training , examined data relating to adolescents 13-19 years ...
Breaking Medicine News(10 mins):Health News:LSDF announces commercialization grants and Entrepreneur Mentoring Program 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 2Health News:New study finds 2.5 million basketball injuries to high school athletes in 6 seasons 3
... on junk foods shown on television poses a real ... them to go for it thereby leading to overweight ... studies have already associated childhood overweight with television viewing, ... childhood overweight and TV viewing is due to children’s ...
... starting from Monday, to encourage the dropouts back to school, ... ,'The Rajya Shiksha Kendra (state education centre) will start ... bring all in the five to 14 years' age group ... said. ,'For the first time, staff from ...
... India firmly establishing itself as a medical tourism destination, ... only upmarket hotels// - travel desks, multi-cuisine menus, translators ... one of the prime requirements of a hospital servicing ... hospital here. ,With the Indian medical ...
... that alcoholics who are alone and suffer from alcohol-use disorders ... great// impact of personality disorders (PDs) on suicide attempt. ... patients who seek treatment for AUDs reports to have attempted ... the general population. The results were published in the journal ...
... The mystery surrounding a rare bone disease called fibrodysplasia ... of a mutant gene// linked to the disease. It ... second skeleton, making movement impossible. Nearly 2500 individuals are ... ,As the disease progresses, the muscles, ligaments, tendons, ...
... is commonly called, is a tropical disease that kills nearly ... able to put an end to this deadly killer, say ... would protect humans and animals. ,The disease is ... The spleen is the organ to be first affected ...
Cached Medicine News:Health News:Junk Food Ads: The Culprit Behind Childhood Obesity 2Health News:World-class Facility A Must To Boost Medical Tourism In India 2Health News:Rare Bone Disease Traced To Faulty FOP Gene 2Health News:Researchers Hopeful About Vaccine For Leishmaniasis 2
Indications For Usage: , ,For use during pulmonary lung function testing...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: